| 000 | 02660 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250514030116.0 | ||
| 264 | 0 | _c20020521 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a1466-4860 | ||
| 024 | 7 |
_a10.1038/sj.thj.6200096 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoulanger, E | |
| 245 | 0 | 0 |
_aA clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. _h[electronic resource] |
| 260 |
_bThe hematology journal : the official journal of the European Haematology Association _c2001 |
||
| 300 |
_a172-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aCidofovir |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCytosine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aGene Rearrangement, B-Lymphocyte, Heavy Chain |
| 650 | 0 | 4 |
_aHerpesviridae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHerpesvirus 8, Human _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aKaryotyping |
| 650 | 0 | 4 |
_aLymphoma, AIDS-Related _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large-Cell, Immunoblastic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOrganophosphonates |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 650 | 0 | 4 |
_aVindesine _xadministration & dosage |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aAgbalika, F | |
| 700 | 1 | _aMaarek, O | |
| 700 | 1 | _aDaniel, M T | |
| 700 | 1 | _aGrollet, L | |
| 700 | 1 | _aMolina, J M | |
| 700 | 1 | _aSigaux, F | |
| 700 | 1 | _aOksenhendler, E | |
| 773 | 0 |
_tThe hematology journal : the official journal of the European Haematology Association _gvol. 2 _gno. 3 _gp. 172-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.thj.6200096 _zAvailable from publisher's website |
| 999 |
_c11824989 _d11824989 |
||